![Dr. Ilana Katz Sand](https://assets.libsyn.com/secure/show/105901/ilana_katz_sand.jpg)
Dr. Katz Sand's recent and current research studies include a clinical trial of dietary interventions for MS and exploring the role of the gut microbiome in MS. Dr. Katz Sand is also a member of the National MS Society's Wellness Research Work Group where, over the past year, she's led the work of the Nutrition Wellness Subgroup.
We're also looking at how a recent announcement about a new MS vaccine caught fire on social media. And we'll tell you what that news was really all about!
Thanks for your feedback! :22
And thank you for this very nice (and totally unexpected) surprise! 1:22
Did you hear about the new MS vaccine? 3:31
Study shows a cancer treatment may protect the blood-brain barrier and reduce neuroinflammation 9:05
Study shows social support is linked to mental health, quality of life, and motor function in people with MS 11:29
My interview with Dr. Ilana Katz Sand 14:23
Share this episode 31:32
Donate to the National MS Society COVID-19 Response Fund 31:52
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/178
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: jon@realtalkms.com
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Give RealTalk MS a Rating and Review
National MS Society COVID-19 Vaccine Guidance for People Living with MS
What You Need to Know About Coronavirus (COVID-19)
Meet the MS Society's 2020 Inspiration Award Winners
STUDY: A Noninflammatory mRNA Vaccine for Treatment of Experimental Autoimmune Encephalomyelitis